Regulation of Cellular division in M. tuberculosis
Regulation of Cellular division in M. tuberculosis
批准号:
7017688
负责人:
RICHARD A SLAYDEN
金额:
$20.97万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-03-01 至 2009-02-28
关键词:
Mycobacterium tuberculosisbacterial geneticsbacterial proteinscell growth regulationchimeric proteinschromosomescytogeneticsgene expressiongene induction /repressiongenetic mappinggreen fluorescent proteinsmicroarray technologymicroorganism cultureoperonpolymerase chain reactionprotein localizationprotein protein interactionprotein structure functionproteomicssite directed mutagenesissynchronous cell divisiontemperature sensitive mutant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
This Proposal is in response to PA-01-113, "Therapeutics Research on AIDS-Associated Opportunistic Infections and Malignancies" and specifically addresses the study of Mycobacterium tuberculosis (MTB). The thrust of this proposal is the development of novel drug targets to counteract multiple drug resistant organisms. The long-term goal of this research program is to develop novel classes of chemotherapeutics that target the regulation, and coordination of chromosomal segregation and cellular division in MTB. Toward this objective we have identified in the MTB genome, gene products that are homologous to proteins associated with these processes in other prokaryotes. Moreover, our preliminary results provide strong evidence that some of these gene products (FtsZ and Ftsl homologues) actively participate in the cellular division of MTB. However, a more extensive analysis of these gene products and global assessment of the potential regulatory networks involved in the division of MTB cells are required. Similar to work with Caulobacter crescentus we hypothesize that DNA microarray analysis with synchronized cultures of MTB will allow us to develop a detailed pattern of gene expression profiles across the entire cell division cycle of this bacterium. Additionally, the use of known inhibitors of early (FtsZ activity) and late (Ftsl activity) events of cell division along with global gene expression studies will further elucidate the regulatory networks that are activated during different stages of cell division. A final analysis of putative regulatory genes already identified and new ones elucidated through gene expression profiling will enable us to develop a detailed picture of the regulatory networks and temporal gene expression responsible for MTB cellular division. Such studies will ensure that future resources are well directed at appropriate chemotherapeutic targets and developing suitable drug discovery strategies. Thus, the studies proposed in this application are designed to examine the replication dynamics of MTB, specifically focusing on cell cycle-regulated genes that are involved in cell division.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
MadR1, a Mycobacterium tuberculosis cell cycle stress response protein that is a member of a widely conserved protein class of prokaryotic, eukaryotic and archeal origin.
MADR1,一种结核分枝杆菌细胞周期应力反应蛋白,是广泛保守的原核生物,真核和弓形的蛋白质类别的成员。
DOI:
10.1016/j.tube.2015.03.005
发表时间:
2015-05
期刊:
Tuberculosis (Edinburgh, Scotland)
影响因子:
--
作者:
[Crew R, Ramirez MV, England K, Slayden RA]
通讯作者:
Slayden RA
DOI:
10.1186/1471-2180-11-79
发表时间:
2011-04-19
期刊:
BMC microbiology
影响因子:
4.2
作者:
[England K, Crew R, Slayden RA]
通讯作者:
Slayden RA
DOI:
10.1186/1471-2180-13-240
发表时间:
2013-10-31
期刊:
BMC microbiology
影响因子:
4.2
作者:
[Ramirez MV, Dawson CC, Crew R, England K, Slayden RA]
通讯作者:
Slayden RA
DOI:
10.4155/fmc.10.220
发表时间:
2010-08
期刊:
Future medicinal chemistry
影响因子:
4.2
作者:
[Kumar K, Awasthi D, Berger WT, Tonge PJ, Slayden RA, Ojima I]
通讯作者:
Ojima I
Development of novel broad spectrum chemotherapeutics against priority pathogens
-
批准号:8261425
-
项目类别:
-
资助金额:$34.07万
-
财政年份:2011
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Genomics Proteomics Core
-
批准号:8261440
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2011
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
-
批准号:7932903
-
项目类别:
-
资助金额:$97.89万
-
财政年份:2009
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
-
批准号:7645264
-
项目类别:
-
资助金额:$97.92万
-
财政年份:2009
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Genomics Proteomics Core
-
批准号:7675680
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2009
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development of novel broad spectrum chemotherapeutics against priority pathogens
-
批准号:7675625
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2009
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development of Novel Chemotherapeutics Against F. tularensis
-
批准号:7688230
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2008
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Post Genomic Bioinformatic Core
-
批准号:7641045
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2008
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Post Genomic Bioinformatic Core
-
批准号:7126265
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2005
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Regulation of Cellular division in M. tuberculosis
-
批准号:6863722
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2003
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Regulation of Cellular division in M. tuberculosis
-
批准号:6654269
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2003
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Regulation of Cellular division in M. tuberculosis
-
批准号:6700743
-
项目类别:
-
资助金额:$23.97万
-
财政年份:2003
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Post Genomic Bioinformatic Core
-
批准号:7451030
-
项目类别:
-
资助金额:$18.43万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development of novel broad spectrum chemotherapeutics against priority pathogens
-
批准号:8070319
-
项目类别:
-
资助金额:$38.35万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Genomics Proteomics Core
-
批准号:8070334
-
项目类别:
-
资助金额:$22.1万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development of novel broad spectrum chemotherapeutics against priority pathogens
-
批准号:8465799
-
项目类别:
-
资助金额:$34.9万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Post Genomic Bioinformatic Core
-
批准号:7310314
-
项目类别:
-
资助金额:$13.7万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
Development of novel broad spectrum chemotherapeutics against priority pathogens
-
批准号:8375702
-
项目类别:
-
资助金额:$29.99万
-
财政年份:--
-
负责人:RICHARD A SLAYDEN
-
依托单位:
海外基金